Ocugen (OCGN) Cash & Equivalents Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Ocugen | 452.01 Mn | 452.01 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -33.71% |
| Jun 30, 2024 | -48.61% |
| Mar 31, 2024 | -16.16% |
| Dec 31, 2023 | 17.97% |
| Sep 30, 2023 | 40.93% |
| Jun 30, 2023 | 67.69% |
| Mar 31, 2023 | 177.54% |
| Dec 31, 2022 | 118.41% |
| Sep 30, 2022 | 87.96% |
| Jun 30, 2022 | 453.42% |
| Mar 31, 2022 | 649.10% |
| Dec 31, 2021 | 287.81% |
| Sep 30, 2021 | 250.94% |
| Jun 30, 2021 | 136.23% |
| Mar 31, 2021 | 42.42% |
| Dec 31, 2020 | 50.29% |
| Sep 30, 2020 | 20.95% |
| Jun 30, 2020 | 12.32% |
| Mar 31, 2020 | -42.01% |
| Dec 31, 2019 | -38.44% |
| Sep 30, 2019 | -26.15% |
| Jun 30, 2019 | -65.07% |
| Mar 31, 2019 | -76.20% |
| Dec 31, 2018 | -62.52% |
| Sep 30, 2018 | -59.62% |
| Jun 30, 2018 | -42.11% |
| Mar 31, 2018 | -33.69% |
| Dec 31, 2017 | -50.54% |
| Sep 30, 2017 | 49.10% |
| Jun 30, 2017 | 10.75% |
| Mar 31, 2017 | 69.54% |